secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001213900-25-003460
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud

OS Therapies completes second closing of $1.05M private placement
-----------------------------------------------------------------

- Second closing sold 263,250 units at $4.00 each, raising $1.053 million in gross proceeds.
- Each unit consists of one share of Series A Convertible Preferred Stock and a warrant to purchase one common share.
- Amendment to securities purchase agreement allows multiple closings up to $10 million, with final closing by Feb 15, 2025.
- Investors in second closing include Tichenor Ventures, LLC; placement agent Brookline Capital Markets received $35,157 cash fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025003460/0001213900-25-003460-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025003460/ea0227697-8k_osthera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-003460

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer